Galena Biopharma (GALE) +6% premarket as it receives a patent from Japan for a Composition of...

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Galena Biopharma (GALE) +6% premarket as it receives a patent from Japan for a Composition of Matter and Method of Treatment patent covering Folate Binding Protein peptide variants for use alone or in combination with FBP cancer vaccine E39. The Japanese patent provides exclusivity in the country until 2022, with additional worldwide patent filings pending.